Edgewise Therapeutics (EWTX) Competitors $12.96 -0.06 (-0.42%) Closing price 07/3/2025 01:04 PM EasternExtended Trading$12.96 0.00 (0.00%) As of 07/3/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EWTX vs. TLX, AXSM, AKRO, ADMA, PCVX, KRYS, RYTM, CYTK, PTCT, and ZLABShould you be buying Edgewise Therapeutics stock or one of its competitors? The main competitors of Edgewise Therapeutics include Telix Pharmaceuticals (TLX), Axsome Therapeutics (AXSM), Akero Therapeutics (AKRO), ADMA Biologics (ADMA), Vaxcyte (PCVX), Krystal Biotech (KRYS), Rhythm Pharmaceuticals (RYTM), Cytokinetics (CYTK), PTC Therapeutics (PTCT), and Zai Lab (ZLAB). These companies are all part of the "pharmaceutical products" industry. Edgewise Therapeutics vs. Its Competitors Telix Pharmaceuticals Axsome Therapeutics Akero Therapeutics ADMA Biologics Vaxcyte Krystal Biotech Rhythm Pharmaceuticals Cytokinetics PTC Therapeutics Zai Lab Edgewise Therapeutics (NASDAQ:EWTX) and Telix Pharmaceuticals (NASDAQ:TLX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends. Does the media refer more to EWTX or TLX? In the previous week, Edgewise Therapeutics had 12 more articles in the media than Telix Pharmaceuticals. MarketBeat recorded 18 mentions for Edgewise Therapeutics and 6 mentions for Telix Pharmaceuticals. Edgewise Therapeutics' average media sentiment score of 0.67 beat Telix Pharmaceuticals' score of 0.67 indicating that Edgewise Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edgewise Therapeutics 5 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Telix Pharmaceuticals 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer EWTX or TLX? Edgewise Therapeutics currently has a consensus price target of $40.00, suggesting a potential upside of 208.76%. Telix Pharmaceuticals has a consensus price target of $22.33, suggesting a potential upside of 38.51%. Given Edgewise Therapeutics' higher possible upside, equities analysts clearly believe Edgewise Therapeutics is more favorable than Telix Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edgewise Therapeutics 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.80Telix Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings and valuation, EWTX or TLX? Telix Pharmaceuticals has higher revenue and earnings than Edgewise Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdgewise TherapeuticsN/AN/A-$133.81M-$1.55-8.36Telix Pharmaceuticals$516.72M10.56$32.93MN/AN/A Is EWTX or TLX more profitable? Telix Pharmaceuticals' return on equity of 0.00% beat Edgewise Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Edgewise TherapeuticsN/A -30.95% -29.45% Telix Pharmaceuticals N/A N/A N/A SummaryTelix Pharmaceuticals beats Edgewise Therapeutics on 5 of the 9 factors compared between the two stocks. Get Edgewise Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EWTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EWTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EWTX vs. The Competition Export to ExcelMetricEdgewise TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.36B$2.89B$5.53B$9.02BDividend YieldN/A2.44%5.22%3.99%P/E Ratio-8.3621.7127.7520.25Price / SalesN/A283.26438.76119.26Price / CashN/A41.7026.2128.59Price / Book2.687.538.025.65Net Income-$133.81M-$55.14M$3.18B$249.15M7 Day Performance-1.18%4.22%2.88%2.91%1 Month Performance-14.99%0.91%1.67%4.11%1 Year Performance-33.32%5.40%34.26%20.98% Edgewise Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EWTXEdgewise Therapeutics2.6422 of 5 stars$12.96-0.4%$40.00+208.8%-33.3%$1.36BN/A-8.3660TLXTelix PharmaceuticalsN/A$16.07+0.4%$22.00+36.9%N/A$5.41B$516.72M0.00N/AAXSMAxsome Therapeutics4.7484 of 5 stars$104.39+1.0%$172.33+65.1%+28.5%$5.09B$385.69M-18.09380Trending NewsAKROAkero Therapeutics3.4504 of 5 stars$53.36-5.0%$82.50+54.6%+142.5%$4.48BN/A-27.3630ADMAADMA Biologics4.1503 of 5 stars$18.21+0.3%$27.67+51.9%+59.6%$4.34B$426.45M21.42530Positive NewsPCVXVaxcyte1.7741 of 5 stars$32.51-0.2%$136.50+319.9%-57.3%$4.20BN/A-8.15160KRYSKrystal Biotech4.5875 of 5 stars$137.46-1.0%$211.13+53.6%-22.4%$4.01B$290.52M33.04210RYTMRhythm Pharmaceuticals3.8195 of 5 stars$63.19+0.7%$77.31+22.3%+55.6%$3.99B$130.13M-22.49140CYTKCytokinetics3.9316 of 5 stars$33.04-0.4%$70.92+114.7%-38.9%$3.96B$18.47M-6.25250PTCTPTC Therapeutics4.3122 of 5 stars$48.84-2.0%$65.00+33.1%+57.7%$3.95B$806.78M7.501,410ZLABZai Lab3.4092 of 5 stars$34.97+0.7%$54.28+55.2%+110.3%$3.86B$398.99M-14.041,869Gap Up Related Companies and Tools Related Companies Telix Pharmaceuticals Competitors Axsome Therapeutics Competitors Akero Therapeutics Competitors ADMA Biologics Competitors Vaxcyte Competitors Krystal Biotech Competitors Rhythm Pharmaceuticals Competitors Cytokinetics Competitors PTC Therapeutics Competitors Zai Lab Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EWTX) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
